Diabetes Nutrition Market Size and Forecast — 2026-2033
Diabetes Nutrition Market is estimated to be valued at USD 6,921.3 Mn in 2026 and is expected to reach USD 10,897.8 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033. Diabetes nutrition include proteins, amino acids, omega-3 fatty acids, alpha-lipoic acid, herbal supplements, soluble fiber, probiotics, carbohydrates, and antioxidants. Diabetes nutrition helps the body to lower the blood glucose level, as extra calories and fats creates the undesirable rise in blood glucose level.
Figure 1. Global Diabetes Nutrition Market Share (%), by Form, 2026
Global Diabetes Nutrition Market - Driver
Increasing strategies adopted by key market players, such as product launches, is expected to drive the global diabetes nutrition market over the forecast period. For instance, in June 2020, Pendulum, a biotechnology company, announced that they had launched pendulum glucose control, the first medical probiotic for the dietary management of type 2 diabetes. Pendulum glucose control targets the gut microbiome to manage blood sugar level.
- Current Industry Events of 2026
- Market Size Estimation
- Regional Breakdown
- Competitive Landscape
- Customer Intelligence
- Segmental Analysis
- Pricing Analysis
- Key Market Drivers, Challenges & Future Trends
- Customized Insights Section
Diabetes Nutrition Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6,921.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.7% | 2033 Value Projection: | USD 10,897.8 Mn |
| Geographies covered: |
| ||
| Segments covered: |
| ||
| Companies covered: | Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players, | ||
| Growth Drivers: |
| ||
| Restraints & Challenges: |
| ||
Figure 2. Global Diabetes Nutrition Market Share (US$ Million), by Region, 2026
Global Diabetes Nutrition Market: Key Developments
The adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global diabetes nutrition market growth. For instance, in December 2021, Danone India, a manufacturer of nutrion products, announced that they had launched Protinex Diabetes Care to address the nutritional requirements of Indians with diabetes. The product aims to provide adequate protein and fiber, which are important nutrients in managing blood sugar levels.
Global Diabetes Nutrition Market: Restraint
Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is expected to hinder the market growth. For instance, in November 2020, the U.S. Food and Drug Administration recalled metformin hydrochrolide,a medication for glucose management in patients with type 2 diabetes which was manufactured by Marksans Pharma, a pharmaceutical company. The drug was recalled due the detection of of high levels of N-nitrosodimethylamine, an organic compound linked to causing cancer in high concentrations.
Global Diabetes Nutrition Market - Key Players
Major players operating in the global diabetes nutrition market include Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players,
Sources
Primary Research Interviews
- Diabetes-specific nutrition manufacturers (e.g., Abbott Glucerna, Nestlé Health Science Boost Glucose Control, Danone Nutricia, Fresenius Kabi)
- Endocrinologists and certified diabetes care and education specialists (CDCES)
- Retail and hospital formulary buyers of oral nutritional supplements
Databases
- International Diabetes Federation (IDF) Diabetes Atlas
- WHO NCD surveillance data
- U.S. CDC National Diabetes Statistics Report
Magazines
- Nutraceuticals World
- NutraIngredients
Journals
- Diabetes Care (ADA)
- The American Journal of Clinical Nutrition
- Clinical Nutrition (ESPEN/Elsevier)
Newspapers
- Reuters Health
- Financial Times – Consumer Health
Associations
- American Diabetes Association (ADA)
- European Association for the Study of Diabetes (EASD)
- Academy of Nutrition and Dietetics
Public Domain Sources
- U.S. FDA medical food guidance
- EFSA health claims on diabetes-related nutrition
- ResearchGate publications on diabetes medical nutrition therapy
Proprietary Elements
- CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 10 years.
Get access to 250+ pages report
Every segment, forecast, competitor profile and data table behind the analysis above — available for instant download.
- ESOMAR Member
- ISO 9001:2015 Certified
- D-U-N-S Registered
- GDPR & CCPA Compliant
Missing comfort of reading report in your local language? Find your preferred language:
Transform your Strategy with Exclusive Trending Reports
Frequently Asked Questions
The Diabetes Nutrition Market is estimated to be valued at USD 6,921.3 Mn in 2026, and is expected to reach USD 10,897.8 Mn by 2033.
The CAGR of the Diabetes Nutrition Market is projected to be 6.7% from 2026 to 2033.
Increasing strategies adopted by key market players such as product launches is expected to drive the market.
Tablets is the leading form segment in the market.
The key factors hampering the market include the increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration.
Major players operating in the market include Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players